Synthesis of Entecavir and Its Novel Class of Analogs
Open Access
- 1 December 2011
- journal article
- unit
- Published by Wiley in Current Protocols in Nucleic Acid Chemistry
- Vol. 47 (1) , 14.7.1-14.7.17
Abstract
Due to the slow kinetics of viral clearance and the spontaneous genetic variability of hepatitis B virus (HBV), antiviral therapy of chronic hepatitis B remains a clinical challenge. Entecavir (S.10; a 2′‐deoxy carbocyclic guanosine analog with an exo‐cyclic double bond on the 5′‐position; Fig. 14.7.1) has been approved in the U.S. for the therapy of chronic hepatitis B. Entecavir is synthesized from D‐ribose via a key allylic alcohol (S.3) intermediate. This intermediate is also utilized to synthesize entecavir‐modified carbocyclic nucleosides S.13, S.15, S.19, and S.22. Curr. Protoc. Nucleic Acid Chem. 47:14.7.1‐14.7.17. © 2011 by John Wiley & Sons, Inc.Keywords
This publication has 25 references indexed in Scilit:
- Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to LamivudineAntimicrobial Agents and Chemotherapy, 2004
- Pentopyranosyl Oligonucleotide Systems. 9th CommunicationHelvetica Chimica Acta, 2003
- Practical Synthesis of d- and l-2-Cyclopentenone and Their Utility for the Synthesis of Carbocyclic Antiviral Nucleosides against Orthopox Viruses (Smallpox, Monkeypox, and Cowpox Virus)The Journal of Organic Chemistry, 2003
- Efficacies of Entecavir against Lamivudine-Resistant Hepatitis B Virus Replication and Recombinant Polymerases In VitroAntimicrobial Agents and Chemotherapy, 2002
- Enantiomeric Synthesis of d- and l-Cyclopentenyl Nucleosides and Their Antiviral Activity Against HIV and West Nile VirusJournal of Medicinal Chemistry, 2001
- The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistanceJournal of Clinical Investigation, 2001
- BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitroBioorganic & Medicinal Chemistry Letters, 1997
- The Mechanism of Inhibition of Hepatitis B Virus Replication by the Carbocyclic Analog of 2′–DeoxyguanosineHepatology, 1992
- 4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl purines and pyrimidines, a new class of anti-herpesvirus agentsAntiviral Research, 1992
- Potent and selective activity of a new carbocyclic nucleoside analog (Carbovir: NSC 614846) against human immunodeficiency virus In vitroBiochemical and Biophysical Research Communications, 1988